8-K: Intelligent Bio Solutions Inc. Announces Updated Share Count Following Equity Sales and Stock Issuance

Intelligent Bio Solutions Inc. reports a total of 4,807,068 outstanding shares of common stock as of January 2, 2025, following recent equity sales and stock issuances.

Summary

• Intelligent Bio Solutions Inc. has updated its total outstanding shares of common stock.
• This update is a result of shares sold through an At The Market Offering Agreement with Ladenburg Thalmann & Co. Inc. dated September 18, 2024.
• Additionally, 8,109 shares of restricted common stock were issued under an agreement with ClearThink Capital Partners LLC dated February 29, 2024.
• As of the close of business on January 2, 2025, the total number of outstanding shares is 4,807,068.

Sentiment

Score: 6

Explanation: The document is a factual update on share count, which is neither positive nor negative in itself. It reflects normal business operations.

Industry Context

This announcement is a routine update on the company's capital structure, which is common for publicly traded companies. It provides transparency to investors regarding the number of outstanding shares.

Comparison to Industry Standards

• The use of an At The Market Offering Agreement is a common method for companies to raise capital in the public markets.
• The issuance of restricted stock for advisory services is also a standard practice.
• The specific number of shares issued and the resulting total outstanding shares are unique to Intelligent Bio Solutions Inc. and would need to be compared to similar companies in the biotechnology sector to assess its impact.

Stakeholder Impact

• Shareholders are informed of the updated share count, which is important for calculating ownership percentages and earnings per share.
• The increased number of shares may have a dilutive effect on existing shareholders.

Key Dates

Keywords

common stock, shares outstanding, equity offering, at the market offering, restricted stock, capital structure, share issuance